Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Ранг среди акций #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Цена акции
$0.02765
Последняя синхронизация: 2024-12-23
Рыночная капитализация
$69.04K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Histogen Inc. (HSTO)

Категория

Коэффициент P/S для Histogen Inc. (HSTO)
Коэффициент P/S на August 2026 TTM: 0.02
Согласно последним финансовым отчетам и цене акций Histogen Inc., текущий коэффициент P/S (TTM) составляет 0.02. В конце 2021 он составлял 1.38.
История P/S для Histogen Inc. с 2011 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
2026 (TTM) 0.02 -67.57%
2022 0.07 -94.87%
2021 1.38 313.79%
2020 0.33 -19.32%
2019 0.41 163.81%
2018 0.16 -58.10%
2017 0.37 -97.50%
2016 14.94 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 43,427.75%
US
10.30 45,287.67%
NL
- -
CH
- -
KR
4.98 21,835.24%
BE